Lobbying campaign killed proposal to set price limits on future coronavirus drugs, vaccines — report
As Congress began drafting the emergency, $8.3 billion spending bill to combat the coronavirus outbreak, Democrats sought to wrap a string around some of that funding.
With $3.1 billion going to support pharmaceutical companies in their R&D efforts against the outbreak, progressive lawmakers wanted to ensure that any drugs or vaccines that emerged from those efforts would be priced affordably, Politico reports. That campaign failed.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.